U.s. patent office rejects axonics' latest challenge to medtronic patents

Medtronic moves for patent infringement litigation to resume dublin , march 21, 2024  /prnewswire/ -- medtronic (nyse:mdt), the global leader in healthcare technology, today announced that the patent trial and appeal board (ptab) of the u.s. patent and trademark office has affirmed the validity of claims in two of its patents in an ongoing patent infringement lawsuit filed by medtronic against axonics over sacral neuromodulation (snm) technologies. cumulatively, the ptab has now upheld the validity of five of the medtronic patents at issue in this lawsuit.
MDT Ratings Summary
MDT Quant Ranking